semaglutide and gallbladder disease Frontiers What are the long-term side

Understanding what to expect and how to minimize discomfort helps you complete your protocol successfully

This multi-receptor mechanism distinguishes it from existing licensed agents such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 agonist)

[15] [16] This research was not specific to retatrutide, was subject to the usual limitations of observational methodology (including confounding), and findings may differ between individual agents and between short- and long-acting formulations

These drugs have not been adequately studied in pregnant women, and animal studies have raised concerns about fetal development

This can contribute to hair loss, especially when combined with nutrition deficiencies